Publication Date:
2009-09-18
Description:
Molecules such as vascular endothelial growth factor (VEGF) or placental growth factor-critical regulators of tumour angiogenesis-are also thought to mobilize into blood circulation bone marrow-derived cells (BMDCs), which may subsequently be recruited to tumours and facilitate tumour growth and metastasis. A study has suggested that BMDCs form 'metastatic niches' in lungs before arrival of cancer cells, and showed that pharmacological inhibition of VEGF receptor 1 (VEGFR1, also known as Flt1)-cognate receptor for VEGF and placental growth factor-prevented BMDC infiltration in lungs and 'metastatic niche' formation. Here we report that blockade of VEGFR1 activity does not affect the rate of spontaneous metastasis formation in a clinically relevant and widely used preclinical model. Therefore, alternative pathways probably mediate the priming of tissues for metastasis.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065241/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉 〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065241/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Dawson, Michelle R -- Duda, Dan G -- Fukumura, Dai -- Jain, Rakesh K -- P01 CA080124/CA/NCI NIH HHS/ -- P01 CA080124-05/CA/NCI NIH HHS/ -- P01 CA080124-06A2/CA/NCI NIH HHS/ -- P01 CA080124-07/CA/NCI NIH HHS/ -- P01 CA080124-08/CA/NCI NIH HHS/ -- P01 CA080124-09/CA/NCI NIH HHS/ -- R01 CA085140/CA/NCI NIH HHS/ -- R01 CA085140-06/CA/NCI NIH HHS/ -- R01 CA085140-07/CA/NCI NIH HHS/ -- R01 CA085140-08/CA/NCI NIH HHS/ -- R01 CA085140-09/CA/NCI NIH HHS/ -- R01 CA096915/CA/NCI NIH HHS/ -- R01 CA096915-04/CA/NCI NIH HHS/ -- R01 CA096915-05/CA/NCI NIH HHS/ -- R01 CA096915-06A1/CA/NCI NIH HHS/ -- R01 CA096915-07/CA/NCI NIH HHS/ -- R01 CA096915-08/CA/NCI NIH HHS/ -- R01 CA115767/CA/NCI NIH HHS/ -- R01 CA115767-01A1/CA/NCI NIH HHS/ -- R01 CA115767-02/CA/NCI NIH HHS/ -- R01 CA115767-03/CA/NCI NIH HHS/ -- R01 CA115767-04/CA/NCI NIH HHS/ -- R01 CA126642/CA/NCI NIH HHS/ -- R01 CA126642-01A1/CA/NCI NIH HHS/ -- R01 CA126642-02/CA/NCI NIH HHS/ -- R24 CA085140/CA/NCI NIH HHS/ -- R24 CA085140-05/CA/NCI NIH HHS/ -- T32 CA073479/CA/NCI NIH HHS/ -- T32 CA073479-08/CA/NCI NIH HHS/ -- T32 CA073479-09/CA/NCI NIH HHS/ -- T32 CA073479-10/CA/NCI NIH HHS/ -- T32 CA073479-11/CA/NCI NIH HHS/ -- T32 CA073479-12/CA/NCI NIH HHS/ -- England -- Nature. 2009 Sep 17;461(7262):E4; discussion E5. doi: 10.1038/nature08254.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Steele Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/19759568" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Bone Marrow Cells/cytology
;
Cell Movement
;
Lung/pathology
;
Lung Neoplasms/*secondary
;
Mice
;
Mice, Inbred C57BL
;
Neoplasm Transplantation
;
Neoplasms/*pathology
;
Vascular Endothelial Growth Factor Receptor-1/*antagonists &
;
inhibitors/deficiency/*metabolism
Print ISSN:
0028-0836
Electronic ISSN:
1476-4687
Topics:
Biology
,
Chemistry and Pharmacology
,
Medicine
,
Natural Sciences in General
,
Physics
